Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

Measuring GFR: a systematic review.

Soveri I, Berg UB, Björk J, Elinder CG, Grubb A, Mejare I, Sterner G, Bäck SE; SBU GFR Review Group.

Am J Kidney Dis. 2014 Sep;64(3):411-24. doi: 10.1053/j.ajkd.2014.04.010. Epub 2014 May 17. Review.

PMID:
24840668
2.

Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation.

Sjöberg B, Qureshi AR, Anderstam B, Alvestrand A, Bárány P.

Blood Purif. 2012;34(3-4):290-7. doi: 10.1159/000342630. Epub 2012 Dec 7.

PMID:
23235124
3.

Combined hypertriglyceridemic and insulin-glucose clamps for the characterization of substrate oxidation and plasma elimination of a long-chain triglyceride emulsion in healthy men.

Åberg V, Thörne A, Alvestrand A, Nordenström J.

Metabolism. 2012 Feb;61(2):221-8. doi: 10.1016/j.metabol.2011.06.011. Epub 2011 Aug 23.

PMID:
21864866
4.

Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study.

Alvestrand A, Ledebo I, Hagerman I, Wingren K, Mattsson E, Qureshi AR, Gutierrez A.

Blood Purif. 2011;32(1):21-9. doi: 10.1159/000323140. Epub 2011 Jan 21.

PMID:
21252503
5.

Postprandial metabolic response to a fat- and carbohydrate-rich meal in patients with chronic kidney disease.

Miyamoto T, Rashid Qureshi A, Yamamoto T, Nakashima A, Lindholm B, Stenvinkel P, Alvestrand A, Axelsson J.

Nephrol Dial Transplant. 2011 Jul;26(7):2231-7. doi: 10.1093/ndt/gfq697. Epub 2010 Nov 23.

PMID:
21098658
6.

Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.

Matsubara K, Stenvinkel P, Qureshi AR, Carrero JJ, Axelsson J, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Suliman ME.

J Nephrol. 2009 Nov-Dec;22(6):774-82.

PMID:
19967657
7.

Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.

Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P.

Am J Kidney Dis. 2009 Jun;53(6):1024-33. doi: 10.1053/j.ajkd.2009.02.008. Epub 2009 Apr 25.

PMID:
19394732
8.

Proteome patterns in uremic plasma.

Naseeb U, Shafqat J, Jägerbrink T, Zarina S, Alvestrand A, Jörnvall H, Axelsson J.

Blood Purif. 2008;26(6):561-8. doi: 10.1159/000178773. Epub 2008 Dec 2.

PMID:
19052450
9.

[Protein-restricted diet good in uremia. Safe, cost-effective--and underused--treatment method].

Alvestrand A.

Lakartidningen. 2008 Jul 23-Aug 5;105(30-31):2084-5. Swedish. No abstract available.

PMID:
18751445
10.

Abdominal aortic calcification in dialysis patients: results of the CORD study.

Honkanen E, Kauppila L, Wikström B, Rensma PL, Krzesinski JM, Aasarod K, Verbeke F, Jensen PB, Mattelaer P, Volck B; CORD study group.

Nephrol Dial Transplant. 2008 Dec;23(12):4009-15. doi: 10.1093/ndt/gfn403. Epub 2008 Aug 1.

11.

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.

Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Tong M, Heimbürger O, Barany P, Alvestrand A, Lindholm B, Stenvinkel P.

Clin J Am Soc Nephrol. 2008 Jul;3(4):976-85. doi: 10.2215/CJN.03960907. Epub 2008 Apr 16.

12.

The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.

Suliman ME, Qureshi AR, Carrero JJ, Bárány P, Yilmaz MI, Snaedal-Jonsdottir S, Alvestrand A, Heimbürger O, Lindholm B, Stenvinkel P.

QJM. 2008 May;101(5):397-405. doi: 10.1093/qjmed/hcn019. Epub 2008 Feb 20.

PMID:
18292098
13.

Acute effects of low and high intravenous doses of furosemide on myocardial function in anuric haemodialysis patients: a tissue Doppler study.

Hayashi SY, Seeberger A, Lind B, Gunnes S, Alvestrand A, do Nascimento MM, Lindholm B, Brodin LA.

Nephrol Dial Transplant. 2008 Apr;23(4):1355-61. Epub 2007 Nov 29.

PMID:
18048421
14.

Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.

Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR, Bárány P, Heimbürger O, Suliman ME, Alvestrand A, Lindholm B, Stenvinkel P.

J Intern Med. 2007 Dec;262(6):690-701. Epub 2007 Oct 1.

15.

Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients.

Stenvinkel P, Rodríguez-Ayala E, Massy ZA, Qureshi AR, Barany P, Fellström B, Heimburger O, Lindholm B, Alvestrand A.

Clin J Am Soc Nephrol. 2006 Mar;1(2):281-7. Epub 2006 Feb 1.

16.

Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.

Tong M, Carrero JJ, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, Axelsson J, Alvestrand A, Stenvinkel P, Lindholm B, Suliman ME.

Clin J Am Soc Nephrol. 2007 Sep;2(5):889-97. Epub 2007 Aug 16.

17.

Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?

Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, Heimbürger O, Barany P, Alvestrand A, Nordfors L, Qureshi AR, Ekström TJ, Schalling M.

J Intern Med. 2007 May;261(5):488-99.

18.

Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite.

Carrero JJ, Qureshi AR, Axelsson J, Avesani CM, Suliman ME, Kato S, Bárány P, Snaedal-Jonsdottir S, Alvestrand A, Heimbürger O, Lindholm B, Stenvinkel P.

Am J Clin Nutr. 2007 Mar;85(3):695-701.

PMID:
17344489
19.

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.

Valli A, Suliman ME, Meert N, Vanholder R, Lindholm B, Stenvinkel P, Watanabe M, Barany P, Alvestrand A, Anderstam B.

Clin Chim Acta. 2007 Apr;379(1-2):87-94. Epub 2007 Jan 16.

PMID:
17292872
20.

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P.

Am J Kidney Dis. 2007 Feb;49(2):237-44.

PMID:
17261426

Supplemental Content

Loading ...
Support Center